Form 4: Verizon Executive Kyle Malady Sells 20,000 Shares of Common Stock

Verizon's EVP and Group CEO-VZ Business, Kyle Malady, sold 20,000 shares of common stock at an average price of $40.54 on January 27, 2025.

Summary

• Kyle Malady, an EVP and Group CEO at Verizon, sold 20,000 shares of Verizon common stock on January 27, 2025.
• The shares were sold at a weighted average price of $40.54 per share.
• The sale was executed in multiple transactions with prices ranging from $40.340 to $40.731 per share.
• Following the transaction, Malady directly owns 45,675 shares and indirectly owns 18,106 shares through a 401(k).

Sentiment

Score: 5

Explanation: The document is a neutral report of a stock sale by an executive, with no indication of positive or negative sentiment.

Industry Context

This is a routine filing related to an executive's stock transactions and is common in publicly traded companies. It does not indicate any specific trend in the telecommunications industry.

Comparison to Industry Standards

• Executive stock sales are a common occurrence in publicly traded companies like Verizon.
• These transactions are typically disclosed through SEC filings, ensuring transparency.
• The sale by Kyle Malady is similar to other executive stock transactions at comparable companies such as AT&T and T-Mobile.

Stakeholder Impact

• The stock sale by an executive may have a minor impact on shareholder sentiment, but is unlikely to significantly affect the company's overall performance.

Key Dates

Keywords

Verizon, stock sale, insider trading, executive, common stock, VZ, Kyle Malady